Ming-Jin Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ming-Jin Xie has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Jie Zhou
School of Chemical Science and Technology, Yunnan University, Kunming 650091, Yunnan, China
6 shared publicationsQi-Hua Zhao
School of Chemical Science and Technology, Yunnan University, Kunming, 650091, Yunnan, China
6 shared publications- Qi-Hua Zhao
Yunnan University
5 shared publications - Sihan Zhou
School of Chemical Science and Technology, Yunnan University, Kunming, PR China
4 shared publications Tian-Tian Wu
School of Chemical Science and Technology, Yunnan University, Kunming, 650091, Yunnan, China
4 shared publicationsWen-Hui Liao
School of Chemical Science and Technology, Yunnan University, Kunming 650091, Yunnan, China
4 shared publications
Latest Publications
- 14 August 2025
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
Multifunctional Drug Delivery Nanoparticles Based on Fe-Containing Metal–Organic Framework for Fluorescence Image-Guided Combined Chemical/Chemodynamic/Photodynamic Colorectal Cancer Treatment
Nanoagents with multiple functions, including fluorescence imaging, photodynamic and chemodynamic properties, and drug delivery capabilities, have great advantages for the synergistic treatment of cancer. However, designing and creating such nanoagents is challenging. Herein, we report a nanocomposite (denoted CPT@MIL(Fe)-TCPP, C@M(Fe)T) based on the MIL-101(Fe)-NH2 framework, which is obtained by loading CPT via electrostatic attraction and modifying TCPP onto MIL-101(Fe)-NH2 through amidation reaction. C@M(Fe)T contains abundant Fe3+, which can undergo a Fenton reaction in the tumor microenvironment rich in GSH and H2O2 to generate hydroxyl radicals and induce oxidative stress. Meanwhile, CPT, when carried by nanomaterials, can effectively accumulate at the tumor site by the EPR effect of nanomaterials to enable chemotherapy. TCPP modified on the surface of the nanomaterial, due to its photosensitive property, can efficiently generate singlet oxygen and realize fluorescence imaging of the cancer location. Both cell assay and animal test show that C@M(Fe)T exhibits a good inhibitory effect on HCT116 colon cancer cells, while avoiding serious injury to other significant organs of the body. Moreover, after the mice were injected with C@M(Fe)T, obvious fluorescent signals were generated at the tumor sites. Overall, the C@M(Fe)T nanocomposite presents a promising strategy for cancer treatment by enabling fluorescence image-guided trimodal CT/CDT/PDT of colorectal cancer and integrating diagnosis and treatment.
- 14 August 2025
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
Multifunctional Drug Delivery Nanoparticles Based on Fe-Containing Metal–Organic Framework for Fluorescence Image-Guided Combined Chemical/Chemodynamic/Photodynamic Colorectal Cancer Treatment
Nanoagents with multiple functions, including fluorescence imaging, photodynamic and chemodynamic properties, and drug delivery capabilities, have great advantages for the synergistic treatment of cancer. However, designing and creating such nanoagents is challenging. Herein, we report a nanocomposite (denoted CPT@MIL(Fe)-TCPP, C@M(Fe)T) based on the MIL-101(Fe)-NH2 framework, which is obtained by loading CPT via electrostatic attraction and modifying TCPP onto MIL-101(Fe)-NH2 through amidation reaction. C@M(Fe)T contains abundant Fe3+, which can undergo a Fenton reaction in the tumor microenvironment rich in GSH and H2O2 to generate hydroxyl radicals and induce oxidative stress. Meanwhile, CPT, when carried by nanomaterials, can effectively accumulate at the tumor site by the EPR effect of nanomaterials to enable chemotherapy. TCPP modified on the surface of the nanomaterial, due to its photosensitive property, can efficiently generate singlet oxygen and realize fluorescence imaging of the cancer location. Both cell assay and animal test show that C@M(Fe)T exhibits a good inhibitory effect on HCT116 colon cancer cells, while avoiding serious injury to other significant organs of the body. Moreover, after the mice were injected with C@M(Fe)T, obvious fluorescent signals were generated at the tumor sites. Overall, the C@M(Fe)T nanocomposite presents a promising strategy for cancer treatment by enabling fluorescence image-guided trimodal CT/CDT/PDT of colorectal cancer and integrating diagnosis and treatment.
- Open Access
Gallium complex K6 inhibits colorectal cancer by increasing ROS levels to induce DNA damage and enhance phosphatase and tensin homolog activity
Colorectal cancer (CRC) is one of the most common malignancies worldwide. In the clinical realm, platinum‐based drugs hold an important role in the chemotherapy of CRC. Nonetheless, a multitude of patients, due to tumor protein 53 (TP53) gene mutations, experience the emergence of drug resistance. This phenomenon gravely impairs the effectiveness of therapy and long‐term prognosis. Gallium, a metallic element akin to iron, has been reported that has the potential to be used to develop new metal anticancer drugs. In this study, we screened and established the gallium complex K6 as a potent antitumor agent in both in vitro and in vivo. K6 exhibited superior efficacy in impeding the growth, proliferation, and viability of CRC cells carrying TP53 mutations compared to oxaliplatin. Mechanistically, K6 escalated reactive oxygen species levels and led deoxyribonucleic acid (DNA) damage. Furthermore, K6 effectively suppressed the phosphoinositide 3‐kinase (PI3K)/protein kinase B (PKB)/glycogen synthase kinase 3 beta (GSK3β) pathway, leading to the degradation of its downstream effectors myelocytomatosis (c‐Myc) and Krueppel‐like factor 5 (KLF5). Conversely, K6 diminished the protein expression of WW domain‐containing protein 1 (WWP1) while activating phosphatase and tensin homolog (PTEN) through c‐Myc degradation. This dual action further demonstrated the potential of K6 as a promising therapeutic compound for TP53‐mutated CRC.
Open AccessGallium complex K6 inhibits colorectal cancer by increasing ROS levels to induce DNA damage and enhance phosphatase and tensin homolog activity
Colorectal cancer (CRC) is one of the most common malignancies worldwide. In the clinical realm, platinum‐based drugs hold an important role in the chemotherapy of CRC. Nonetheless, a multitude of patients, due to tumor protein 53 (TP53) gene mutations, experience the emergence of drug resistance. This phenomenon gravely impairs the effectiveness of therapy and long‐term prognosis. Gallium, a metallic element akin to iron, has been reported that has the potential to be used to develop new metal anticancer drugs. In this study, we screened and established the gallium complex K6 as a potent antitumor agent in both in vitro and in vivo. K6 exhibited superior efficacy in impeding the growth, proliferation, and viability of CRC cells carrying TP53 mutations compared to oxaliplatin. Mechanistically, K6 escalated reactive oxygen species levels and led deoxyribonucleic acid (DNA) damage. Furthermore, K6 effectively suppressed the phosphoinositide 3‐kinase (PI3K)/protein kinase B (PKB)/glycogen synthase kinase 3 beta (GSK3β) pathway, leading to the degradation of its downstream effectors myelocytomatosis (c‐Myc) and Krueppel‐like factor 5 (KLF5). Conversely, K6 diminished the protein expression of WW domain‐containing protein 1 (WWP1) while activating phosphatase and tensin homolog (PTEN) through c‐Myc degradation. This dual action further demonstrated the potential of K6 as a promising therapeutic compound for TP53‐mutated CRC.
- 9 May 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 15 (8) , 2663-2676
Responsive ZIF-90 nanocomposite material: targeted delivery of 10-hydroxycamptothecine to enhance the therapeutic effect of colon cancer (HCT116) cells
There is significant value in developing multifunctional drug delivery systems with high therapeutic efficiency for diagnosing and treating tumors. In this study, we synthesized the ATP-triggered and pH-sensitive material ZIF-90 using the liquid-phase diffusion method. This was done to load 10-hydroxycamptothecin (HCPT), and the FA-PEG-NH2 conjugate was synthesized through an amidation reaction. We further modified the HCPT@ZIF-90 nanocomposite by employing the Schiff base reaction to create the HCPT@ZIF-90-PEG-FA nanomaterial. Drug loading test results revealed a high HCPT drug loading of up to 22.3% by weight. In the drug release experiment, the cumulative drug release of HCPT@ZIF-90 nanomaterials in pH 5.4 and ATP solutions was the highest after 72 hours. The active targeted delivery of FA and the dual-responsive release of HCPT by ZIF-90 significantly enhanced the therapeutic effect of HCPT@ZIF-90-PEG-FA on human colon cancer cells (HCT116). In the cytotoxicity test, when 100 μg mL−1 of HCPT@ZIF-90-PEG-FA was incubated with cells, the cell survival rate was 16.61 ± 1.19%, significantly lower than that of the other experimental groups. This result indicates that HCPT@ZIF-90-PEG-FA exhibits excellent anti-tumor activity. Cell cycle experiments have shown that HCPT@ZIF-90-PEG-FA may inhibit the proliferation of cancer cells by blocking DNA synthesis and halting cell cycle progression. Cell uptake experiments showed that HCPT@ZIF-90-PEG-FA was mainly present in the cytoplasm of HCT1116 cells, indicating successful cellular entry of the drug to exert its therapeutic effect. In vivo experiments also demonstrated that HCPT@ZIF-90-PEG-FA nanomaterials can effectively eradicate HCT116 tumors. The utilization of the nano-drug carrier ZIF-90, along with the modification with PEG-FA, notably improved the therapeutic efficacy of HCPT. These results suggest that the system, with its active targeted delivery of FA and dual-responsive release of HCPT, could present a novel strategy for treating human colorectal cancer.
- 9 May 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 15 (8) , 2663-2676
Responsive ZIF-90 nanocomposite material: targeted delivery of 10-hydroxycamptothecine to enhance the therapeutic effect of colon cancer (HCT116) cells
There is significant value in developing multifunctional drug delivery systems with high therapeutic efficiency for diagnosing and treating tumors. In this study, we synthesized the ATP-triggered and pH-sensitive material ZIF-90 using the liquid-phase diffusion method. This was done to load 10-hydroxycamptothecin (HCPT), and the FA-PEG-NH2 conjugate was synthesized through an amidation reaction. We further modified the HCPT@ZIF-90 nanocomposite by employing the Schiff base reaction to create the HCPT@ZIF-90-PEG-FA nanomaterial. Drug loading test results revealed a high HCPT drug loading of up to 22.3% by weight. In the drug release experiment, the cumulative drug release of HCPT@ZIF-90 nanomaterials in pH 5.4 and ATP solutions was the highest after 72 hours. The active targeted delivery of FA and the dual-responsive release of HCPT by ZIF-90 significantly enhanced the therapeutic effect of HCPT@ZIF-90-PEG-FA on human colon cancer cells (HCT116). In the cytotoxicity test, when 100 μg mL−1 of HCPT@ZIF-90-PEG-FA was incubated with cells, the cell survival rate was 16.61 ± 1.19%, significantly lower than that of the other experimental groups. This result indicates that HCPT@ZIF-90-PEG-FA exhibits excellent anti-tumor activity. Cell cycle experiments have shown that HCPT@ZIF-90-PEG-FA may inhibit the proliferation of cancer cells by blocking DNA synthesis and halting cell cycle progression. Cell uptake experiments showed that HCPT@ZIF-90-PEG-FA was mainly present in the cytoplasm of HCT1116 cells, indicating successful cellular entry of the drug to exert its therapeutic effect. In vivo experiments also demonstrated that HCPT@ZIF-90-PEG-FA nanomaterials can effectively eradicate HCT116 tumors. The utilization of the nano-drug carrier ZIF-90, along with the modification with PEG-FA, notably improved the therapeutic efficacy of HCPT. These results suggest that the system, with its active targeted delivery of FA and dual-responsive release of HCPT, could present a novel strategy for treating human colorectal cancer.
- 22 May 2023
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 37 (7)
Two novel silver(I) phenanthroline derivative complexes induce G2/M phase cycle arrest and apoptosis of MDA‐MB‐231 cancer cells by multiple mechanisms
Two novel silver(I) phenanthroline derivative complexes (P‐235 and P‐239) have been synthesized and characterized by IR, HPLC‐MS, and 1HNMR. The cytotoxicity of two complexes exhibited significant cytotoxicity against human breast cancer (MDA‐MB‐231) cell line (IC50 = 0.48 ± 0.01 and 0.12 ± 0.01 μM) and less toxicity than cisplatin by MTT assays. Furthermore, anticancer mechanistic studies showed that P‐235 and P‐239 induced G2/M phase cell cycle arrest to inhibit the growth of MDA‐MB‐231 cells. Flow cytometry analysis showed that MDA‐MB‐231 cells could be significantly induced to undergo apoptosis by P‐235 and P‐239. And P‐235‐ and P‐239‐induced apoptosis was linked with reactive oxygen species (ROS) production. Further study revealed that P‐235 and P‐239 cause mitochondrial membrane potential depolarization and destroy mitochondrial membrane potential.
- 22 May 2023
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 37 (7)
Two novel silver(I) phenanthroline derivative complexes induce G2/M phase cycle arrest and apoptosis of MDA‐MB‐231 cancer cells by multiple mechanisms
Two novel silver(I) phenanthroline derivative complexes (P‐235 and P‐239) have been synthesized and characterized by IR, HPLC‐MS, and 1HNMR. The cytotoxicity of two complexes exhibited significant cytotoxicity against human breast cancer (MDA‐MB‐231) cell line (IC50 = 0.48 ± 0.01 and 0.12 ± 0.01 μM) and less toxicity than cisplatin by MTT assays. Furthermore, anticancer mechanistic studies showed that P‐235 and P‐239 induced G2/M phase cell cycle arrest to inhibit the growth of MDA‐MB‐231 cells. Flow cytometry analysis showed that MDA‐MB‐231 cells could be significantly induced to undergo apoptosis by P‐235 and P‐239. And P‐235‐ and P‐239‐induced apoptosis was linked with reactive oxygen species (ROS) production. Further study revealed that P‐235 and P‐239 cause mitochondrial membrane potential depolarization and destroy mitochondrial membrane potential.
- Open Access
- 8 February 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (7) , 6945-6958
(8-Hydroxyquinoline) Gallium(III) Complex with High Antineoplastic Efficacy for Treating Colon Cancer via Multiple Mechanisms
A series of (8-hydroxyquinoline) gallium(III) complexes (CP-1-4) was synthesized and characterized by single X-ray crystallography and density functional theory (DFT) calculation. The cytotoxicity of the four gallium complexes toward a human nonsmall cell lung cancer cell line (A549), human colon cancer cell line (HCT116), and human normal hepatocyte cell line (LO2) was evaluated using MTT assays. CP-4 exhibited excellent cytotoxicity against HCT116 cancer cells (IC50 = 1.2 ± 0.3 μM) and lower toxicity than cisplatin and oxaliplatin. We also evaluated the anticancer mechanism studies in cell uptake, reactive oxygen species analysis, cell cycle, wound-healing, and Western blotting assays. The results showed that CP-4 affected the expression of DNA-related proteins, which led to the apoptosis of cancer cells. Moreover, molecular docking tests of CP-4 were performed to predict other binding sites and to confirm its higher binding force to disulfide isomerase (PDI) proteins. The emissive properties of CP-4 suggest that this complex can be used for colon cancer diagnosis and treatment, as well as in vivo imaging. These results also provide a foundation for the development of gallium complexes as potent anticancer agents.
- 8 February 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (7) , 6945-6958
Open Access(8-Hydroxyquinoline) Gallium(III) Complex with High Antineoplastic Efficacy for Treating Colon Cancer via Multiple Mechanisms
A series of (8-hydroxyquinoline) gallium(III) complexes (CP-1-4) was synthesized and characterized by single X-ray crystallography and density functional theory (DFT) calculation. The cytotoxicity of the four gallium complexes toward a human nonsmall cell lung cancer cell line (A549), human colon cancer cell line (HCT116), and human normal hepatocyte cell line (LO2) was evaluated using MTT assays. CP-4 exhibited excellent cytotoxicity against HCT116 cancer cells (IC50 = 1.2 ± 0.3 μM) and lower toxicity than cisplatin and oxaliplatin. We also evaluated the anticancer mechanism studies in cell uptake, reactive oxygen species analysis, cell cycle, wound-healing, and Western blotting assays. The results showed that CP-4 affected the expression of DNA-related proteins, which led to the apoptosis of cancer cells. Moreover, molecular docking tests of CP-4 were performed to predict other binding sites and to confirm its higher binding force to disulfide isomerase (PDI) proteins. The emissive properties of CP-4 suggest that this complex can be used for colon cancer diagnosis and treatment, as well as in vivo imaging. These results also provide a foundation for the development of gallium complexes as potent anticancer agents.
- Open Access
- 1 January 2023
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 18, 225-241
Gallium Metal−Organic Nanoparticles with Albumin-Stabilized and Loaded Graphene for Enhanced Delivery to HCT116 Cells
Background: Gallium (III) metal-organic complexes have been shown to have the ability to inhibit tumor growth, but the poor water solubility of many of the complexes precludes further application. The use of materials with high biocompatibility as drug delivery carriers for metal-organic complexes to enhance the bioavailability of the drug is a feasible approach. Methods: Here, we modified the ligands of gallium 8-hydroxyquinolinate complex with good clinical anticancer activity by replacing the 8-hydroxyquinoline ligands with 5-bromo-8-hydroxyquinoline (HBrQ), and the resulting Ga(III) + HBrQ complex had poor water solubility. Two biocompatible materials, bovine serum albumin (BSA) and graphene oxide (GO), were used to synthesize the corresponding Ga(III) + HBrQ complex nanoparticles (NPs) BSA/Ga/HBrQ NPs and GO/Ga/HBrQ NPs in different ways to enhance the drug delivery of the metal complex. Results: Both of BSA/Ga/HBrQ NPs and GO/Ga/HBrQ NPs can maintain stable existence in different solution states. In vitro cytotoxicity test showed that two nanomedicines had excellent anti-proliferation effect on HCT116 cells, which shown higher level of intracellular ROS and apoptosis ratio than that of cisplatin and oxaliplatin. In addition, the superior emissive properties of BSA/Ga/HBrQ NPs and GO/Ga/HBrQ NPs allow their use for in vivo imaging showing highly effective therapy in HCT116 tumor-bearing mouse models. Conclusion: The use of biocompatible materials for the preparation of NPs against poorly biocompatible metal-organic complexes to construct drug delivery systems is a promising strategy that can further improve drug delivery and therapeutic efficacy. Graphical Abstract:
- 1 January 2023
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 18, 225-241
Open AccessGallium Metal−Organic Nanoparticles with Albumin-Stabilized and Loaded Graphene for Enhanced Delivery to HCT116 Cells
Background: Gallium (III) metal-organic complexes have been shown to have the ability to inhibit tumor growth, but the poor water solubility of many of the complexes precludes further application. The use of materials with high biocompatibility as drug delivery carriers for metal-organic complexes to enhance the bioavailability of the drug is a feasible approach. Methods: Here, we modified the ligands of gallium 8-hydroxyquinolinate complex with good clinical anticancer activity by replacing the 8-hydroxyquinoline ligands with 5-bromo-8-hydroxyquinoline (HBrQ), and the resulting Ga(III) + HBrQ complex had poor water solubility. Two biocompatible materials, bovine serum albumin (BSA) and graphene oxide (GO), were used to synthesize the corresponding Ga(III) + HBrQ complex nanoparticles (NPs) BSA/Ga/HBrQ NPs and GO/Ga/HBrQ NPs in different ways to enhance the drug delivery of the metal complex. Results: Both of BSA/Ga/HBrQ NPs and GO/Ga/HBrQ NPs can maintain stable existence in different solution states. In vitro cytotoxicity test showed that two nanomedicines had excellent anti-proliferation effect on HCT116 cells, which shown higher level of intracellular ROS and apoptosis ratio than that of cisplatin and oxaliplatin. In addition, the superior emissive properties of BSA/Ga/HBrQ NPs and GO/Ga/HBrQ NPs allow their use for in vivo imaging showing highly effective therapy in HCT116 tumor-bearing mouse models. Conclusion: The use of biocompatible materials for the preparation of NPs against poorly biocompatible metal-organic complexes to construct drug delivery systems is a promising strategy that can further improve drug delivery and therapeutic efficacy. Graphical Abstract:
- 31 October 2022
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 61 (45) , 18044-18058
Anion-Controlled Assembly of a Silver-Responsive Bifunctional Coordination Polymer with Detection and Large Adsorption Capacity
The recognition and adsorption of silver ions (Ag+) from industrial wastewater are necessary but still challenging. Herein, we constructed four Zn(II)-based coordination polymers (CPs), namely, [Zn(btap)2(NO3)2]n (1), [Zn(btap)(SO4)(H2O)3]n (2), {[Zn(btap)2(H2O)2]·(ClO4)2}n (3), and [Zn(btap)Cl2]n (4), by using 3,5-bis(triazol-1-yl)pyridine (btap) with different anionic Zn(II) salts. The crystal structures of 1-4, varying from one-dimensional beaded (1) and zigzag chain (2) to two-dimensional sql (3) and bex (4) typologies, were regulated by the coordination modes of btap and the counter-anions. The water stability, pH stability, thermostability, and luminescent properties of the CPs were investigated. The luminescence performances in a series of cations and anions were also explored. Considering the high density of chloride groups in the structure, 4 showed luminescence sensing for Ag+ [KSV = 9188.45 M-1 and a limit of detection (LOD) of 4.9 μM], as well as an excellent ability for Ag+ adsorption in aqueous solution (maximum adsorption capacity, 653.3 mg/g). Additionally, anti-interference experiments revealed that 4 had excellent recognition and adsorption capacities for Ag+ even when multiple ions coexisted. Moreover, XRD, EDS, and XPS analyses confirmed that the coordination of Ag+ with chloride groups in 4 resulted in excellent adsorption capacity and prevented ligand-to-ligand electron transfer, showing excellent detection ability. Suitable coordination sites were introduced to interact strongly with Ag+, along with detection and large adsorption capacity. Our strategy can effectively design and develop multifunctional CP-based materials, which are applicable in removal processes and environmental protection, by regulating anions in the self-assembly and introducing CP functional groups.
- 31 October 2022
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 61 (45) , 18044-18058
Anion-Controlled Assembly of a Silver-Responsive Bifunctional Coordination Polymer with Detection and Large Adsorption Capacity
The recognition and adsorption of silver ions (Ag+) from industrial wastewater are necessary but still challenging. Herein, we constructed four Zn(II)-based coordination polymers (CPs), namely, [Zn(btap)2(NO3)2]n (1), [Zn(btap)(SO4)(H2O)3]n (2), {[Zn(btap)2(H2O)2]·(ClO4)2}n (3), and [Zn(btap)Cl2]n (4), by using 3,5-bis(triazol-1-yl)pyridine (btap) with different anionic Zn(II) salts. The crystal structures of 1-4, varying from one-dimensional beaded (1) and zigzag chain (2) to two-dimensional sql (3) and bex (4) typologies, were regulated by the coordination modes of btap and the counter-anions. The water stability, pH stability, thermostability, and luminescent properties of the CPs were investigated. The luminescence performances in a series of cations and anions were also explored. Considering the high density of chloride groups in the structure, 4 showed luminescence sensing for Ag+ [KSV = 9188.45 M-1 and a limit of detection (LOD) of 4.9 μM], as well as an excellent ability for Ag+ adsorption in aqueous solution (maximum adsorption capacity, 653.3 mg/g). Additionally, anti-interference experiments revealed that 4 had excellent recognition and adsorption capacities for Ag+ even when multiple ions coexisted. Moreover, XRD, EDS, and XPS analyses confirmed that the coordination of Ag+ with chloride groups in 4 resulted in excellent adsorption capacity and prevented ligand-to-ligand electron transfer, showing excellent detection ability. Suitable coordination sites were introduced to interact strongly with Ag+, along with detection and large adsorption capacity. Our strategy can effectively design and develop multifunctional CP-based materials, which are applicable in removal processes and environmental protection, by regulating anions in the self-assembly and introducing CP functional groups.
- 12 November 2021
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 50 (48) , 18044-18052
Anion-controlled Zn(ii) coordination polymers with 1-(tetrazo-5-yl)-3-(triazo-1-yl) benzene as an assembling ligand: synthesis, characterization, and efficient detection of tryptophan in water
The triazole/tetrazole N-donor ligand of Httb is rarely studied in the construction of CPs. A controlling effect of anions on supramolecular architectures has been observed. CP 2 has been proved to be the best tryptophan sensor.
- 12 November 2021
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 50 (48) , 18044-18052
Anion-controlled Zn(ii) coordination polymers with 1-(tetrazo-5-yl)-3-(triazo-1-yl) benzene as an assembling ligand: synthesis, characterization, and efficient detection of tryptophan in water
The triazole/tetrazole N-donor ligand of Httb is rarely studied in the construction of CPs. A controlling effect of anions on supramolecular architectures has been observed. CP 2 has been proved to be the best tryptophan sensor.